🇺🇸 FDA
Pipeline program

AC-203, Vehicle ointment (Placebo of AC-203 Diacerein 1% Ointment, EU)

AC-203-EBS-007

Phase 3 small_molecule active

Quick answer

AC-203, Vehicle ointment (Placebo of AC-203 Diacerein 1% Ointment, EU) for Generalized Epidermolysis Bullosa Simplex (EBS) is a Phase 3 program (small_molecule) at Ology Bioservices Ireland LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
Ology Bioservices Ireland LTD
Indication
Generalized Epidermolysis Bullosa Simplex (EBS)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials